Kostas Syrigos

Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non–Small-Cell Lung Cancer

Luis Paz‐Ares, Bonne Biesma, David F. Heigener et al. · Journal of Clinical Oncology · 2012 · 256 citations · Full text

Vinorelbine Plus Cisplatin Versus Docetaxel Plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Randomized Trial

Vassilis Georgoulias, Alexandros Ardavanis, Xanthi Tsiafaki et al. · Journal of Clinical Oncology · 2005 · 163 citations · Full text

Advanced Nsclc, Oncology, Medicine +11

The Biological Role of PI3K Pathway in Lung Cancer

Evangelos Sarris, Muhammad Wasif Saif, Kostas Syrigos · Pharmaceuticals · 2012 · 129 citations · Full text

Signaling Pathway, Cell Signaling, Pi3k/akt/mtor Signal Pathway +13

Role and cost effectiveness of PET/CT in management of patients with cancer.

Muhammad Wasif Saif, Ifigenia Tzannou, Nektaria Makrilia et al. · PubMed · 2010 · 110 citations

Computed Tomography, Oncologic Imaging, Pet-mri +20

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism

Isabelle Mahé, Marc Carrier, D. Mayeur et al. · New England Journal of Medicine · 2025 · 85 citations